Condition: Chronic Subdural Hematoma · Sponsor: Montefiore Medical Center
This multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety profile.
This description comes directly from the study's public registry record.
Muhammed Amir Essibayi, MD · 347-908-1889 · muhammedamir.essibayi@einsteinmed.edu
Always discuss trial participation with your own doctor first.
| Baptist Health South Florida, Inc. | Coral Gables, Florida, United States | Recruiting |
| Mayo Clinic Florida | Jacksonville, Florida, United States | Completed |
| Orlando Regional Medical Center | Orlando, Florida, United States | Recruiting |
| University of Illinois Chicago | Chicago, Illinois, United States | Completed |
| University of Chicago Medicine | Chicago, Illinois, United States | Recruiting |
| The University of Iowa | Iowa City, Iowa, United States | Completed |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| Beth Israel Deaconess Medical Center (BIDMC)/Harvard Medical School | Boston, Massachusetts, United States | Recruiting |
| Lahey Hospital and Medical Center | Burlington, Massachusetts, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Completed |
| Montefiore Medical Center | The Bronx, New York, United States | Recruiting |
| Geisinger Health | Danville, Pennsylvania, United States | Completed |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06181994